Mehran Score for Post-PCI Contrast Nephropathy
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۱۰۰۰ • واحد: mL
حداقل ۰ — حداکثر ۲۰۰ • واحد: mL/min/1.73 m²
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–5
- Moderate Risk6–10
- High Risk11–15
- Very High Risk16–999
The Mehran Score for Post-PCI Contrast Nephropathy calculates predicting risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). Key inputs include hypotension. Scores guide initiating guideline-directed medical therapy, antithrombotic or anticoagulant regimens, or urgent coronary angiography. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). The score uses 8 clinical variables to stratify patients into risk categories and guide preventive strategies.
Clinical Indication
The Mehran Score for Post-PCI Contrast Nephropathy is indicated for bedside clinical practice to support Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI). The score uses 8 clinical variables to stratify patients into risk categories and guide preventive strategies.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult patients presenting with suspected or established coronary artery disease, cardiac arrhythmias, congestive heart failure, or valvular heart defects. Clinical application is indicated across Emergency department, cardiac care unit (CCU), cardiac catheterization laboratory, and outpatient cardiology clinics.
Limitations & Contraindications
In hemodynamically unstable cardiogenic shock, cardiac arrest, or refractory acute coronary syndromes, immediate resuscitation and coronary angiography supersede scoring.
Clinical Pearls & Action Plan
Continuous 12-lead ECG monitoring, serial cardiac troponin measurements, and echocardiographic evaluation align with ESC/ACC/AHA clinical practice guidelines.
Score = Hypotension (5 points) + IABP (5 points) + CHF (5 points) + Age >75 (4 points) + Anemia (3 points) + Diabetes (3 points) + (Contrast volume in mL / 100) + eGFR points (6 if <20, 4 if 20-39, 2 if 40-59, 0 if ≥60)
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| hypotension | string | Yes | Systolic blood pressure <80 mmHg for ≥1 hour requiring inotropic support or intra-aortic balloon pump within 24 hours of catheterization |
| intra_aortic_balloon_pump | string | Yes | Use of intra-aortic balloon pump (IABP) |
| congestive_heart_failure | string | Yes | CHF class III/IV by New York Heart Association Classification and/or history of pulmonary edema |
| age_over_75 | string | Yes | Age greater than 75 years |
| anemia | string | Yes | Baseline hematocrit <39% for men and <36% for women |
| diabetes | string | Yes | History of diabetes mellitus |
| contrast_volume_ml | float | Yes | Total volume of contrast media used (in mL)(mL) |
| egfr | float | Yes | Estimated glomerular filtration rate(mL/min/1.73 m²) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–5 | Low Risk | Low risk of CIN |
| 6–10 | Moderate Risk | Moderate risk of CIN |
| 11–15 | High Risk | High risk of CIN |
| 16–999 | Very High Risk | Very high risk of CIN |
Evidence-Based References (EBM)
- Mehran R, Aymong ED, Nikolsky E, Lasic Z, Iakovou I, Fahy M, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9. doi: 10.1016/j.jacc.2004.06.068.DOI: 10.1016/j.jacc.2004.06.068
- Wi J, Ko YG, Kim JS, Kim BK, Choi D, Ha JW, et al. Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011 Nov;97(21):1753-7. doi: 10.1136/hrt.2010.218677.DOI: 10.1136/hrt.2010.218677
- Narula A, Mehran R, Weisz G, Dangas GD, Yu J, Généreux P, et al. Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014 Jun 14;35(23):1533-40. doi: 10.1093/eurheartj/ehu063.DOI: 10.1093/eurheartj/ehu063